Masimo launches CE marking of Eve™ CCHD New-born screening application

Masimo has launched the CE marking of Eve™, a critical congenital heart disease (CCHD) new-born screening application, for the Rad-97™ Pulse CO-Oximeter®. Eve combines the power of Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry with a pre-ductal to post-ductal synchronization algorithm designed to reduce calculation errors.

Eve simplifies the CCHD screening process by providing visual instructions, animations, an automatic synchronization algorithm, and a detailed, easy-to-interpret display of screening results. The ability to label results with unique patient identifiers for both mother and new-born facilitates intuitive session management and seamless electronic charting. Eve also allows clinicians to incorporate perfusion index into the screening, which has been shown to increase sensitivity to the detection of CCHD in infants with pathologically low perfusion.

Contact details:
Evan Lamb
Masimo
Phone: (949) 396-3376
Email: elamb@masimo.com

Also Read |  New 4D printing technology can turn smart 3D print gel into any form